References
- Labrecque G, Belanger PM. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 1991;52:95–107
- Duncan WC. Circadian rhythms and the pharm acology of affective illness. Pharmacol Ther 1996;71:253–312
- Reinberg AE. Concepts of circadian chronopha rmacology. Ann N Y Acad Sci 1991;618:102–15
- Nayak UY, Shavi GV, Nayak Y. Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system. J Control Release 2009;136:125–31
- Schellekens RCA, Stellaard F, Mitrovic D. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. J Control Release 2008;132:91–8
- Sharma S, Pawar A. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 2006;313:150–8
- Makino K, Idenuma R, Murakami T. Design of a rate- and time-programming drug release device using a hydrogel: pulsatile drug release from k-carrageenan hydrogel device by surface erosion of the hydrogel. Colloids Surf B 2001;20:355–9
- Liu LX, Wang XC. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery. Eur J Pharm Biopharm 2008;68:298–302
- Li YQ, Rauth AM, Wu XY. Prediction of kinetics of doxorubicin release from sulfopropyl dextranion-exchange microspheres using artificial neural networks. Eur J Pharm Sci 2005;24:401–10
- Costa P, Lobo JM. Modeling and comparison of dissolution pro Àles. Eur J Pharm 2001;13:123–33
- Grassi M, Grassi M. Mathematical modelling and controlled drug delivery: matrix systems. Curr Drug Deliv 2005;2:97–116
- Liu L, Ku J, Khang G. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release 2000;68:145–56
- Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release system of pseudoephedrine. J Control Release 2003;89:5–18
- Ozdemir N, Sahin J. Design of a controlled release osmotic pump system of ibuprofen. Int J Pharm 1997;158:91–7
- Liu L, Khang G, Rhee JM. Monolithic osmotic tablet system for nifedipine delivery. J Control Release 2000;67:309–22
- Garg A, Gupta M, Bhargava HN. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm 2007;67:725–31
- Verma RK, Kaushal AM, Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int J Pharm 2003;263:9–24
- Zentner GM, Rork GS, Himmelstein KJ. The controlled porosity osmotic pump. J Control Release 1985;1:269–82
- Appel LE, Zentner GM. Use of modified ethyl cellulose lattices for microporous coating of osmotic tablets. Pharm Res 1991;8:600–4
- Okimoto K, Ohike A, Ibuki R. Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent. J Control Release 1999;60:311–19
- Kao C-C, Chen S-C, Sheu M-T. Lag time method to delay drug release to various sites in the gastrointestinal tract. J Control Release 1997;44:263–70
- Baker R. Controlled release of biologically active agents: diffusion-controlled system. New York: Wiley; 1987:46 pp